Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

  19,500      
Direct Value   $6,853,083    

Indirect Value

  $132,600      
Total Shares   312,921      
Total Value   $6,985,683      


Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $999,049 Biocryst Pharmaceuticals Inc
 $402,836 Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $999,049 Biocryst Pharmaceuticals Inc
 $402,836
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    4   
    5    

     Stock price went up :

    0   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   -4.0   
   1.5   
     Percentage Gain/Loss :
   -31.1%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2023-06-13 63,339 2019-03-12 0    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2022-05-31 4 A $9.31 $5,297 D/D 569 33,728 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-02-02 4 OE $10.09 $252,250 D/D 25,000 221,667 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-04-30 4 B $10.37 $15,825 D/D 1,526 33,560 2.74 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-02-26 4 A $10.78 $9,993 D/D 927 31,496 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2009-04-30 4 A $10.93 $16,560 D/D 1,515 33,916 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2009-10-31 5 B $11.60 $4,119 D/D 355 51,271 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-04-30 4 A $11.64 $17,827 D/D 1,532 21,387 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-10-29 4 A $11.64 $3,421 D/D 294 37,881 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-04-29 4 A $11.64 $18,583 D/D 1,597 31,478 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-09-08 4 OE $11.74 $410,900 D/D 35,000 72,587 0 -
ACER Acer Therapeutics Inc Director   –       •      –    2017-12-14 4 B $12.00 $24,000 D/D 2,000 13,905 2.39 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-11-30 4 A $12.06 $4,993 D/D 414 32,858 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-10-31 5 B $13.23 $2,658 D/D 201 46,679 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-10-31 5 B $13.35 $16,506 D/D 1,236 32,401 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-17 4 OE $14.39 $7,195 D/D 500 30,381 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-11-18 4 OE $14.39 $451,486 D/D 31,375 61,756 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-10-28 4 OE $14.39 $242,831 D/D 16,875 63,353 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2012-05-11 4 OE $14.39 $324,480 D/D 21,530 68,340 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-05-14 4 AS $15.09 $46,206 D/D (3,062) 245,732 0 %
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-03-05 4 S $15.36 $66,939 D/D (4,359) 256,357 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-05-28 4 A $15.77 $9,998 D/D 634 32,130 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2020-05-05 4 AS $15.88 $39,700 D/D (2,500) 253,857 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-08-31 4 A $15.92 $4,999 D/D 314 32,444 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-03-17 4 OE $16.23 $162,300 D/D 10,000 206,667 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-04-16 4 OE $16.23 $162,300 D/D 10,000 198,940 0 -

  169  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed